International Niemann–Pick Disease Alliance
AQNEURSA is approved in the U.S. and Europe for neurological manifestations of Niemann-Pick disease type C and in the...
Read storyLEMBAZ™ (adrabetadex) is the first medicine to address the underlying cholesterol trafficking defect that causes Niemann-Pick disease, type C...
Read storyINPDA has been informed by Sanofi of supply interruptions affecting Xenpozyme (olipudase alfa), a treatment for Acid Sphingomyelinase Deficiency...
Read story